Squamous cell carcinoma of the skin: Difference between revisions
| Line 42: | Line 42: | ||
*'''[[Squamous cell carcinoma surgical treatment|Surgical treatment]]''' | *'''[[Squamous cell carcinoma surgical treatment|Surgical treatment]]''' | ||
*'''[[Primary Prevention]]''' | *'''[[Primary Prevention]]''' | ||
*'''[[Secondary Prevention''' | *'''[[Secondary Prevention]]''' | ||
==Future and Investigational treatment strategies== | ==Future and Investigational treatment strategies== | ||
Revision as of 22:04, 16 June 2012
For patient information click here
Template:DiseaseDisorder infobox
|
Squamous cell carcinoma of the skin Microchapters |
|
Differentiating Squamous cell carcinoma of the skin from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Squamous cell carcinoma of the skin On the Web |
|
American Roentgen Ray Society Images of Squamous cell carcinoma of the skin |
|
Directions to Hospitals Treating Squamous cell carcinoma of the skin |
|
Risk calculators and risk factors for Squamous cell carcinoma of the skin |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Govindavarjhulla, M.B.B.S. [2], Raviteja Guddeti, M.B.B.S. [3]
Overview
Historical Aspects
Pathophysiology
Epidemiology and Demographics
Risk Factors
Screening
Causes of Squamous cell carcinoma
Differential Diagnosis
Natural History Complications and Prognosis
History & Symptoms
Physical Examination
Staging
Treatment
Future and Investigational treatment strategies
In 2007, Australian biopharmaceutical company Clinuvel Pharmaceuticals Limited began clinical trials with a melanocyte-stimulating hormone called melanotan (known by the International Nonproprietary Name afamelanotide, formerly CUV1647)[1] to provide photoprotection for organ transplant patients against squamous cell carcinoma of the skin and actinic keratosis.[2][3]
Cetuximab a monoclonal antibody that targets the epidermal growth factor receptor (EGFR), has antitumor activity in patients with advanced squamous cell carcinoma of the skin, as initially suggested by case reports.
References
- ↑ "World Health Organisation assigns CUV1647 generic name" (PDF). Clinuvel. 2008. Retrieved 2008-06-17.
- ↑ Clinuvel » Investors » FAQs
- ↑ PharmaAsia - Clinuvel’s Drug Begins Global Phase II Skin Cancer Trials
External links
- Information on Squamous Cell Carcinoma from The Skin Cancer Foundation
- Article by Stephen D Hess, MD, PhD
- DermNet NZ: Squamous cell carcinoma
- Squamous cell carcinoma in transplant recipients
Template:Tumors of bone, cartilage, skin, connective, and soft tissue Template:Respiratory and intrathoracic neoplasia Template:Genital neoplasia Template:Epithelial neoplasms
de:Plattenepithelkarzinom he:קרצינומת תאי קשקש nl:Plaveiselcelcarcinoom